CO5070608A1 - Metodo para aumentar la permeabilidad del tejido corneo humano - Google Patents

Metodo para aumentar la permeabilidad del tejido corneo humano

Info

Publication number
CO5070608A1
CO5070608A1 CO99019173A CO99019173A CO5070608A1 CO 5070608 A1 CO5070608 A1 CO 5070608A1 CO 99019173 A CO99019173 A CO 99019173A CO 99019173 A CO99019173 A CO 99019173A CO 5070608 A1 CO5070608 A1 CO 5070608A1
Authority
CO
Colombia
Prior art keywords
permeability
increasing
human
cornee
fabric
Prior art date
Application number
CO99019173A
Other languages
English (en)
Inventor
Sun Ying
Liu Jue-Chen
Elizabeth Kimbleton
Jonas C T Wang
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of CO5070608A1 publication Critical patent/CO5070608A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se relaciona con un método para aumentar la permeabilidad del tejido córneo humano a los agentes activos, que consiste en aplicar una composición que comprende una cantidad efectiva de uno o más compuestos con contenido de azufre a los tejidos córneos humanos durante un período de tiempo suficiente para incrementar la permeabilidad del tejido córneo humano a los agentes activos. <EMI FILE="99019173_1" ID="1" IMF=JPEG >
CO99019173A 1998-03-31 1999-03-30 Metodo para aumentar la permeabilidad del tejido corneo humano CO5070608A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8021298P 1998-03-31 1998-03-31

Publications (1)

Publication Number Publication Date
CO5070608A1 true CO5070608A1 (es) 2001-08-28

Family

ID=22155965

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99019173A CO5070608A1 (es) 1998-03-31 1999-03-30 Metodo para aumentar la permeabilidad del tejido corneo humano

Country Status (4)

Country Link
AR (1) AR016200A1 (es)
AU (1) AU3212099A (es)
CO (1) CO5070608A1 (es)
WO (1) WO1999049895A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
PT1891960E (pt) * 2006-08-17 2010-01-04 Klever Mode S L Fórmula farmacêutica para o tratamento de doenças da pele
WO2011155887A1 (en) * 2010-06-07 2011-12-15 Topical Pharma Ab Kit for the treatment of onychomycosis by nitric oxide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956467A (en) * 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
IT1249047B (it) * 1991-02-21 1995-02-11 Zambon Spa Composizione farmaceutica per il trattamento della cataratta
FR2681782B1 (fr) * 1991-09-26 1993-12-17 Oreal Composition pour le traitement des ongles contenant un aminoacide soufre.
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
WO1999049895A2 (en) 1999-10-07
AR016200A1 (es) 2001-06-20
AU3212099A (en) 1999-10-18
WO1999049895A3 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
DK0987998T3 (da) Decellulering af væv
DE59309781D1 (de) Selbsttätig expandierender gewebeexpander
BR9711562A (pt) Dispositivo m-dico para a coloca-Æo de materiais sÄlidos
BR0212867A (pt) Emulsão de água-em-óleo, composição, e, métodos para umectar pele de mamìfero, para desinfetar tecido de mamìfero e para suprir um agente farmacêutico a um mamìfero
IL114352A0 (en) Catheter
ATE454166T1 (de) Behandlung von patienten die eine knochenmarktransplantation oder eine transplantation peripherer blutstammzellen erhalten mit anti-cd20 antikörpern
FI952701A (fi) Metallisen kirurgisen istukkaan käsittelymenetelmä
DE69929428D1 (de) Chirurgisch implantierbare knieprothese
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
CO5180581A1 (es) Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
GR890100652A (el) Οφθαλμικη ραφη και οργανα για την εφαρμογη χρησεως της ραφης.
MX9703609A (es) Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
DK1021712T3 (da) Phosphorescerende dendritiske makromolekylære forbindelser til billeddannelse af oxygen i væv
ES2153851T3 (es) Tratamiento de la atrofia de la piel y de la vagina.
ATE389411T1 (de) Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz
DE69821731D1 (de) Augenbandage zum Gebrauch nach intraokularen Operationen
TR200003280T2 (tr) Katarakt çıkarma için cerrahi prosedürlerin kolaylaştırılması için bir vital boyanın kullanımı.
TR200400526T4 (tr) Göz kurumasının tedavisi için lipoksin A4 ve analogları
PT1263363E (pt) Composicao visco-elastica colorida
DK0998287T3 (da) Anvendelse af levobupivacain
GB9807298D0 (en) Medicament
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
DE29901517U1 (de) Vorrichtung zur abtragenden Behandlung von Hornhaut, insbesondere bei der Fußpflege
CO5070608A1 (es) Metodo para aumentar la permeabilidad del tejido corneo humano